Oral Ipamorelin: What the Research Notes

The short version

Searches for "ipamorelin oral" usually mean: can you swallow it instead of injecting it? The research answer is no. Ipamorelin itself is not orally bioavailable — taken by mouth, stomach and gut enzymes break the peptide down before it reaches the bloodstream. Every study that showed an effect delivered it by needle: into a vein, under the skin, into the nose, or into the abdomen.

There is no approved oral ipamorelin, and no published human study of an oral form. Some chemists have built separate, engineered molecules derived from ipamorelin that survive the gut better in animals, but those are different compounds, not ipamorelin you can buy in a capsule. Anything sold as "oral ipamorelin" is making a claim the research does not support.

Routes the research actually used

The published record runs entirely through injectable and mucosal routes. The human pharmacokinetic study used intravenous infusion (4.21–140.45 nmol/kg over 15 minutes) ^[2]. The single human Phase 2 trial used intravenous dosing (0.03 mg/kg twice daily) ^[3]. Rodent efficacy work used subcutaneous injection — the rat bone-growth study dosed 18, 90, and 450 micrograms per day under the skin ^[4] — and intraperitoneal injection, as in the 2024 ferret weight-loss study (1–3 mg/kg) ^[5]. Intranasal delivery has been characterized in rodents at roughly 20% bioavailability. Oral bioavailability has been reported only for engineered ipamorelin-derived analogs (around 10% in dog), not for ipamorelin itself.

Why peptides resist the pill form

Peptides are chains of amino acids, and the digestive tract is built to take such chains apart. Stomach acid and protease enzymes (molecular scissors that cut peptide bonds) degrade most peptide drugs before absorption, which is why insulin and most peptide therapeutics are injected. Ipamorelin's design already includes protease-resistant building blocks — an alpha-aminoisobutyric acid at one end and D-form amino acids — which extend its life in the bloodstream once injected ^[1]. But that engineering buys plasma stability, not survival of a trip through the gut. Reaching the receptor by mouth is a much harder problem than reaching it by needle.

What this means for the regulatory picture

No oral form changes the headline status: ipamorelin is not approved in any form, by any route. The community route of choice — subcutaneous self-injection — has no published human safety or pharmacokinetic characterization at all, and oral material has even less standing. For the doses studied and the route considerations in full, see doses studied; for the approval record, see regulatory status.